Bitget Boosts Trust with Chainlink Proof of Reserve Bitget Boosts Trust with Chainlink Proof of Reserve VICTORIA, Seychelles, Aug. 20, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has announced the adoption of Chainlink Proof of Reserve on Ethereum to provide real-time transparency for its wrapped Bitcoin
Bitget Debuts First-Ever RWA Index Perpetuals Featuring Major Real-World Assets Bitget Debuts First-Ever RWA Index Perpetuals Featuring Major Real-World Assets VICTORIA, Seychelles, Aug. 20, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, today announced the launch of the industry’s first RWA (Real-World Asset) Index Perpetual Contract. This
MotoGP Meets Web3 With Bitget’s Smarter Speed Challenge MotoGP Meets Web3 With Bitget’s Smarter Speed Challenge VICTORIA, Seychelles, Aug. 19, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s leading cryptocurrency exchange and Web3 company, is revving up for the second half of the MotoGP season with the official launch of the Smarter Speed
CGTN: Xizang’s development is a story of transformation and renewal CGTN: Xizang’s development is a story of transformation and renewalBEIJING, Aug. 19, 2025 (GLOBE NEWSWIRE) — The story of today’s Xizang Autonomous Region can’t be told in isolation. The profound transformation, resilience and renewal that people see today are a
Bitget Opens Access for AI Agent-Assisted Trading Boosting Wider Crypto Adoption Bitget Opens Access for AI Agent-Assisted Trading Boosting Wider Crypto Adoption VICTORIA, Seychelles, Aug. 19, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has announced its AI-powered trading assistant, GetAgent, is now available to all users. First
REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment
